NYSE: CVSCVS HEALTH Corp Stock Ownership
Insider buying vs selling
Have CVS HEALTH Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Karen S. Lynch | President and CEO | 2021-11-28 | 14,121 | $91.52 | $1.29MSell |
| Fernando Aguirre | Director | 2021-11-17 | 1,253 | $92.73 | $116.19kBuy |
| Tony L. White | Director | 2021-11-17 | 1,314 | $92.73 | $121.85kBuy |
| Mary L. Schapiro | Director | 2021-11-17 | 417 | $92.73 | $38.67kBuy |
| Nancy Ann Deparle | Director | 2021-11-17 | 1,334 | $92.73 | $123.70kBuy |
| Jean Pierre Millon | Director | 2021-11-17 | 1,253 | $92.73 | $116.19kBuy |
| Anne A. Finucane | Director | 2021-11-17 | 1,314 | $92.73 | $121.85kBuy |
| David W. Dorman | Director | 2021-11-17 | 3,154 | $92.73 | $292.47kBuy |
| Jonathan C. Roberts | EVP & Chief Operating Officer | 2021-11-03 | 108,870 | $45.93 | $5.00MBuy |
| Jonathan C. Roberts | EVP & Chief Operating Officer | 2021-11-03 | 108,870 | $95.00 | $10.34MSell |
CVS insiders have sold more CVS shares than they have bought in the last year
Ownership
CVS Shareholders
What type of owners hold CVS HEALTH Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.21% | 108,357,306 | $9.65B | Institution |
| Blackrock Inc | 7.17% | 94,594,948 | $8.42B | Institution |
| State Street Corp | 4.19% | 55,250,146 | $4.92B | Institution |
| Capital World Investors | 3.83% | 50,573,988 | $4.50B | Institution |
| Capital International Investors | 2.08% | 27,406,753 | $2.44B | Institution |
| Morgan Stanley | 1.73% | 22,849,435 | $2.03B | Institution |
| Geode Capital Management LLC | 1.64% | 21,691,019 | $1.93B | Institution |
| Jpmorgan Chase Co | 1.53% | 20,179,811 | $1.80B | Institution |
| Invesco Ltd | 1.36% | 18,011,567 | $1.60B | Institution |
| Bank Of America Corp | 1.31% | 17,232,348 | $1.53B | Institution |
CVS HEALTH Corp Stock Ownership FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.